However, opposite results have been observed in other studies in which blocking NGF through the administration of anti-NGF antibodies was effective in reducing colonic hyperalgesia in murine models of colitis [69,70], suggesting that NGF may represent a therapeutic target for pain related to this disease. Here, NGF is linked to colitis.